Drugs / CPG10101
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT00142103 | Sep 2005 → Feb 2007 | chronic hepatitis C virus infection | Pfizer | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT00277238 | Feb 2006 → Jul 2007 | chronic hepatitis C virus infection | Pfizer | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CPG 10101 | “CPG 10101 Combination Therapy for the Treatment of Hepatitis C: A Phase II Randomized, Open Label, Multi-Center, Parallel Arm, Controlled Trial of CPG 10101 at Two Different...” NCT00277238 ↗ |
| Route | Subcutaneous | “CPG10101 subcutaneous” NCT00142103 ↗ |